| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncotelic Therapeutics, Inc. | Director | Stock Options | 451K | 08 Jul 2021 | Direct | ||
| RenovoRx, Inc. | Director | Stock Options (right to buy) | 25.1K | 01 Oct 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNXT | RenovoRx, Inc. | 01 Oct 2023 | 1 | $0 | 4 | Director | 02 Oct 2023, 16:15 |
| RNXT | RenovoRx, Inc. | 01 Oct 2022 | 1 | $0 | 4 | Director | 04 Oct 2022, 16:27 |
| RNXT | RenovoRx, Inc. | 10 Mar 2022 | 2 | $0 | 4 | Director | 14 Mar 2022, 16:41 |
| RNXT | RenovoRx, Inc. | 01 Oct 2021 | 2 | $0 | 4 | Director | 05 Oct 2021, 16:23 |
| RNXT | RenovoRx, Inc. | 25 Aug 2021 | 0 | $0 | 3 | Director | 25 Aug 2021, 17:34 |
| OTLC | Oncotelic Therapeutics, Inc. | 08 Jul 2021 | 1 | $0 | 4 | Director | 16 Jul 2021, 17:36 |